1. 545PClinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials. (23rd October 2018) Authors: Montagut, C; Alonso, V; Escudero, P; Fernández-Martos, C; Salud Salvia, A; Méndez, M; Gallego Plazas, J; Rodriguez, J R; Martín-Richard, M; Fernández-Plana, J; Aparicio, J; Feliu Batlle, J; García de Albéniz, X; Rojo, F; Fernández, V; Claes, B; Maertens, G G; Sablon, E; Jacobs, B A W; Maurel, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Detection of somatic RAS mutations in circulating tumor DNA from metastatic colorectal cancer patients: are we ready for clinical use?. (14th March 2018) Authors: Montagut, C; Tsui, D W; Diaz, L A Journal: Annals of oncology Issue: Volume 29:Number 5(2018) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial. (14th November 2017) Authors: Abad, A; Martínez-Balibrea, E; Viéitez, J M; Alonso-Orduña, V; García Alfonso, P; Manzano, J L; Massutí, B; Benavides, M; Carrato, A; Zanui, M; Gallego, J; Grávalos, C; Conde, V; Provencio, M; Valladares-Ayerbes, M; Salazar, R; Sastre, J; Montagut, C; Rivera, F; Aranda, E Journal: Annals of oncology Issue: Volume 29:Number 2(2018) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. KRAS mutations in ctDNA: a promising new biomarker in advanced pancreatic cancer. (13th November 2018) Authors: Montagut, C; Vidal, J; Visa, L Journal: Annals of oncology Issue: Volume 29:Number 12(2018) Page Start: 2280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LBA24A multi-omic analysis for prospective patient stratification in localised colorectal cancer (CRC). (23rd October 2018) Authors: Tarazona Llavero, N; Fontana, E; Gambardella, V; Gimeno-Valiente, F; Castillo, J; Calon, A; Martínez-Ciarpaglini, C; Peiró-Chova, L; Huerta, M; Zuñiga, S; Rentero-Garrido, P; Montón-Bueno, J; Roda, D; Roselló, S; Bellosillo, B; Vivancos, A; Nyamundana, G; Montagut, C; Sadanandam, A; Cervantes, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. O-006Ultra-selection of metastatic colorectal cancer patients using next generation sequencing platform to improve clinical efficacy of anti-EGFR therapy. (20th June 2018) Authors: Vidal, J; Dalmeses, A; Vivas, C Santos; Garcia-Carbonero, R; García-Alfonso, P; Carrato, A; Elez, E; Ortiz, M; Losa, F; Massutí, B; Valladares-Ayerbes, M; Manzano, J; de Prado, J Vieitez; Gallego, J; Grávalos, C; Varela, M; Azuara, D; Tabernero, J; Salazar, R; Aranda, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. O-006Ultra-selection of metastatic colorectal cancer patients using next generation sequencing platform to improve clinical efficacy of anti-EGFR therapy. (20th June 2018) Authors: Vidal, J; Dalmeses, A; Vivas, C Santos; Garcia-Carbonero, R; García-Alfonso, P; Carrato, A; Elez, E; Ortiz, M; Losa, F; Massutí, B; Valladares-Ayerbes, M; Manzano, J; de Prado, J Vieitez; Gallego, J; Grávalos, C; Varela, M; Azuara, D; Tabernero, J; Salazar, R; Aranda, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. O-027BEACON CRC study safety lead-in: Assessment of the BRAF inhibitor encorafenib + MEK inhibitor binimetinib + anti–epidermal growth factor receptor antibody cetuximab for BRAFV600E metastatic colorectal cancer. (20th June 2018) Authors: Van Cutsem, E; Cuyle, P; Huijberts, S; Schellens, J; Elez, E; Yaeger, R; Fakih, M; Montagut, C; Peeters, M; Desai, J; Yoshino, T; Ciardiello, F; Wasan, H; Maharry, K; Christy-Bittel, J; Gollerkeri, A; Kopetz, S; Grothey, A; Tabernero, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-285Optimizing the use of EGFR antibodies across the continuum of care in mCRC: Effect of online education on clinician knowledge, competence and confidence. (20th June 2018) Authors: Fisher, G; Guerra, W; Day, C; Montagut, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy. (23rd January 2019) Authors: Vidal, J; Bellosillo, B; Santos Vivas, C; García-Alfonso, P; Carrato, A; Cano, M T; García-Carbonero, R; Élez, E; Losa, F; Massutí, B; Valladares-Ayerbes, M; Viéitez, J M; Manzano, J L; Azuara, D; Gallego, J; Pairet, S; Capellá, G; Salazar, R; Tabernero, J; Aranda, E Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗